ClinicalTrials.gov
public full text
Public Domain
Sevoflurane in COVID-19 ARDS (SevCov)
The purpose of this trial is to study the effect of initial temporary sevoflurane sedation on mortality and persistent organ dysfunction (POD) in survivors at day 28 after ICU admission in the population of patients suffering from COVID-19 ARDS.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacokinetic of Sevoflurane During a 48h Sedation in Intensive Care Unit With AnaConDa®#898071
- Isoflurane for difficult sedation in critically ill children: a retrospective analysis in a mixed pediatric intensive care population#398353
- Sedation Depth in Neurocritical Care#1060599
- Sedation Management in Pediatric Patients Supported on Mechanical Ventilation#1010563
- 6-month Follow up After Sevoflurane Postconditioning#836163
Record · ID 850570
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive